Kingstown Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTSW
LP
RCM
AGC
HIM
CCP
MI
HCM
PAMP
MCM
Kingstown Capital Management's DRTSW Position: Q3 2022 in Review
Kingstown Capital Management reduced its Alpha Tau Medical Warrant (DRTSW) stake by 69% in Q3 2022, selling an estimated $65.4K and leaving 50,000 shares worth $22K. The position accounts for 0.07% of the portfolio, ranked #16.
Kingstown Capital Management first reported a position in DRTSW in Q1 2022 and has held it in 3 quarters since. The position peaked at $98K in Q1 2022. 38 funds tracked by Wall St. Rank hold DRTSW as of Q3 2022.
- Kingstown Capital Management held 50,000 shares of Alpha Tau Medical Warrant worth $22K as of Q3 2022.
- Kingstown Capital Management sold 110,821 Alpha Tau Medical Warrant shares in Q3 2022, an estimated $65.4K.
- Alpha Tau Medical Warrant made up 0.07% of Kingstown Capital Management's portfolio in Q3 2022, its #16 holding.
- Kingstown Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 3 quarters since.
- Kingstown Capital Management's Alpha Tau Medical Warrant position peaked at $98K in Q1 2022.
- 38 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2022.
Based on Kingstown Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.